Dr. Ithaar Derweesh, MD

Dr. Derweesh practices at UCSD Hillcrest Medical Center in San Diego, California.

Dr. Derweesh's NPI, 1003873720, was assigned on April 27, 2006. Dr. Derweesh graduated from Pritzker School of Medicine in 1995. Dr. Derweesh holds California license C53383.

Dr. Derweesh's primary practice is UCSD Hillcrest Medical Center, at 200 W Arbor Dr, San Diego, CA 92103 in San Diego County. The practice phone is (619) 543-6222.

Dr. Derweesh's primary practice is UCSD Hillcrest Medical Center in San Diego, California. Dr. Derweesh is also affiliated with Hillcrest Medical Center. The medical group on file is Rush University Internists. Dmand AI also links Dr. Derweesh to 4 more hospitals, 2 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Derweesh practices, 6 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Derweesh's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Derweesh is board certified in urology by the American Board of Urology. Dmand AI has Dr. Derweesh's licenses on file in 5 states: California, Missouri, Tennessee, Ohio and Connecticut.

Dmand AI lists bladder disease, enlarged prostate, erectile dysfunction, kidney cysts, kidney removal surgery, prostate cancer, urinary endoscopy and urine flow blockage among the conditions Dr. Derweesh treats.

CMS data shows 661 Medicare services from Dr. Derweesh across 9 procedure codes in 2024, for 455 Medicare patients. Medicare paid $62,135 for them.

CMS counts 455 Medicare patients who saw Dr. Derweesh in 2024. The largest group is 65 to 74, with 214 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 27% are also on Medicaid. Their average risk score is 1.81, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Derweesh's median patient age at 71, with 33% women.

In 2024, Dr. Derweesh wrote 201 Medicare Part D claims for 74 patients. 96% of them were for generic drugs. CMS names the drug for 123 of them, across 2 drugs with 11 or more claims each, at $1,931 in total drug cost. In 2023, CMS named 75 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Derweesh for performance year 2024, reported as part of a group. Dr. Derweesh accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Derweesh as offering telehealth.

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 205 papers to Dr. Derweesh, published from 2006 to 2025. 2022 was the busiest year, with 21. The most frequent topics are Kidney Neoplasms, Nephrectomy and Carcinoma, Renal Cell. Dr. Derweesh has published most often in BJU Int. Dr. Derweesh's most frequent co-authors are Reza Mehrazin, MD, Rana Ramzi McKay, MD and Steven Campbell, MD.

Dmand AI links Dr. Derweesh to 1 clinical trial. Conditions studied include Carcinoma, Renal Cell and Kidney Neoplasms.

CMS Open Payments shows 46 general payments to Dr. Derweesh from 23 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 40% of the total. Genentech, Inc. paid the most, $5,115.

Dmand AI lists 10 awards for Dr. Derweesh, most recently Assistant Editor, Journal of Urology in 2017.

Dr. Derweesh graduated from Pritzker School of Medicine in 1995. Dr. Derweesh is a member of AUA and Society of Urologic Oncology.

Dr. Derweesh is in network with 15 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.